Your browser doesn't support javascript.
loading
Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach.
Kong, Seong-Ho; Kurokawa, Yukinori; Yook, Jeong-Hwan; Cho, Haruhiko; Kwon, Oh-Kyoung; Masuzawa, Toru; Lee, Kyung Hee; Matsumoto, Sohei; Park, Young Soo; Honda, Hiroshi; Ryu, Seung-Wan; Ishikawa, Takashi; Kang, Hye Jin; Nabeshima, Kazuhito; Im, Seock-Ah; Shimokawa, Toshio; Kang, Yoon-Koo; Hirota, Seiichi; Yang, Han-Kwang; Nishida, Toshirou.
Affiliation
  • Kong SH; Department of Surgery, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine Cancer Research Institute, 101, Daehak-ro, Jongno-gu, Seoul, 0380, South Korea.
  • Kurokawa Y; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Yook JH; Department of Surgery, University of Ulsan College of Medicine Asan Medical Center, Seoul, South Korea.
  • Cho H; Department of Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Kwon OK; Department of Surgery, Kyungpook National University School of Medicine, Kyungpook National University Chilgok Hospital, Daegu, South Korea.
  • Masuzawa T; Department of Surgery, Osaka Police Hospital, Osaka, Japan.
  • Lee KH; Department of Hemato-Oncology, Yeungnam University College of Medicine, Daegu, South Korea.
  • Matsumoto S; Department of Surgery, Nara Medical University, Nara, Japan.
  • Park YS; Department of Pathology, University of Ulsan College of Medicine Asan Medical Center, Seoul, South Korea.
  • Honda H; Department of Surgery, Sendai Open Hospital, Sendai, Japan.
  • Ryu SW; Department of Surgery, Keimyung University Dongsan Hospital, Daegu, South Korea.
  • Ishikawa T; Department of Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Kang HJ; Department of Internal Medicine, Korea Institute of Radiological & Medical Sciences, Korea Cancer Center Hospital, Seoul, South Korea.
  • Nabeshima K; Department of Surgery, Tokai University, Hiratsuka, Kanagawa, Japan.
  • Im SA; Department of Internal Medicine, Seoul National University Hospital and Seoul National University College of Medicine Cancer Research Institute, Seoul, South Korea.
  • Shimokawa T; Clinical Study Support Center, Wakayama Medical University Hospital, Wakayama, Japan.
  • Kang YK; Department of Oncology, University of Ulsan College of Medicine Asan Medical Center, Seoul, South Korea.
  • Hirota S; Department of Surgical Pathology, Hyogo Medical University School of Medicine, Nishinomiya, Japan.
  • Yang HK; Department of Surgery, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine Cancer Research Institute, 101, Daehak-ro, Jongno-gu, Seoul, 0380, South Korea. hkyang@snu.ac.kr.
  • Nishida T; Department of Surgery, Japan Community Health Care Organization Osaka Hospital, Osaka, Japan.
Gastric Cancer ; 26(5): 775-787, 2023 09.
Article in En | MEDLINE | ID: mdl-37351703
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Gastrointestinal Stromal Tumors / Imatinib Mesylate Type of study: Prognostic_studies Limits: Humans Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2023 Document type: Article Affiliation country: South Korea
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Gastrointestinal Stromal Tumors / Imatinib Mesylate Type of study: Prognostic_studies Limits: Humans Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2023 Document type: Article Affiliation country: South Korea